Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) EBT (2016 - 2025)

Historic EBT for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $1.6 million.

  • Xtant Medical Holdings' EBT rose 13153.97% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 11341.05%. This contributed to the annual value of -$16.3 million for FY2024, which is 146817.74% down from last year.
  • Per Xtant Medical Holdings' latest filing, its EBT stood at $1.6 million for Q3 2025, which was up 13153.97% from $3.8 million recorded in Q2 2025.
  • Xtant Medical Holdings' 5-year EBT high stood at $6.9 million for Q3 2023, and its period low was -$5.0 million during Q3 2024.
  • In the last 5 years, Xtant Medical Holdings' EBT had a median value of -$2.2 million in 2023 and averaged -$1.3 million.
  • As far as peak fluctuations go, Xtant Medical Holdings' EBT crashed by 3640000.0% in 2022, and later skyrocketed by 39619.66% in 2023.
  • Over the past 5 years, Xtant Medical Holdings' EBT (Quarter) stood at -$2.4 million in 2021, then rose by 7.95% to -$2.2 million in 2022, then crashed by 70.29% to -$3.7 million in 2023, then grew by 15.62% to -$3.1 million in 2024, then soared by 149.78% to $1.6 million in 2025.
  • Its EBT stands at $1.6 million for Q3 2025, versus $3.8 million for Q2 2025 and $33000.0 for Q1 2025.